MDS is a bone marrow failure disorder
MDS is a blood cancer
Learn More >
Rafael Bejar
Season 2: Episode 2:

The role of genetics in MDS management

Drs. Rafael Bejar
  • Listen on Spotify

Drs. Rafael Bejar (San Diego) and Moshe Mittelman (Tel Aviv) discuss several papers highlighting the role of genetics in MDS diagnosis, follow up and prediction of treatment. They also discuss the role of the newly approved luspatercept in the treatment of anemic transfusion-dependent patients with lower-risk MDS



If you have questions or feedback on this podcast, please feel free to contact us. We would love to hear from you!

Contact Us

Enjoying Our Podcasts?

If you are enjoying our podcasts and other resources, please consider becoming a Professional Member of the MDS Foundation.

Learn More About Membership
Review answers to commonly asked questions or get answers to your questions from an MDS expert